BIOMAT Database Logo BIOMAT Database Logo

Benign Bence Jones gammopathy. 1980

G Paladini, and P G Sala, and P A Santini

A case of isolated lambda-light chain proteinemia and proteinuria is reported. During a 42-month follow-up, no sign of myelomatosis or amyloidosis developed and Bence Jones proteinuria remained nearly of the same magnitude. This case of apparently idiopathic Bence Jones gammopathy, the first lambda-type so far reported, is added to similar observations to give further support to the contention that a benign counterparty to light-chain myeloma may exist.

UI MeSH Term Description Entries
D007122 Immunoelectrophoresis A technique that combines protein electrophoresis and double immunodiffusion. In this procedure proteins are first separated by gel electrophoresis (usually agarose), then made visible by immunodiffusion of specific antibodies. A distinct elliptical precipitin arc results for each protein detectable by the antisera.
D007146 Immunoglobulin lambda-Chains One of the types of light chain subunits of the immunoglobulins with a molecular weight of approximately 22 kDa. Ig lambda Chains,Immunoglobulins, lambda-Chain,Immunoglobulin lambda-Chain,lambda-1-Immunoglobulin,lambda-2-Immunoglobulin,lambda-Chain Immunoglobulins,lambda-Immunoglobulin Light Chain,lambda-Immunoglobulin Light Chains,lambda-x Immunoglobulin,Chains, Ig lambda,Chains, lambda-Immunoglobulin Light,Immunoglobulin lambda Chain,Immunoglobulin lambda Chains,Immunoglobulin, lambda-x,Immunoglobulins, lambda Chain,Light Chain, lambda-Immunoglobulin,Light Chains, lambda-Immunoglobulin,lambda 1 Immunoglobulin,lambda 2 Immunoglobulin,lambda Chain Immunoglobulins,lambda Chains, Ig,lambda Immunoglobulin Light Chain,lambda Immunoglobulin Light Chains,lambda x Immunoglobulin,lambda-Chain, Immunoglobulin,lambda-Chains, Immunoglobulin
D007147 Immunoglobulin Light Chains Polypeptide chains, consisting of 211 to 217 amino acid residues and having a molecular weight of approximately 22 kDa. There are two major types of light chains, kappa and lambda. Two Ig light chains and two Ig heavy chains (IMMUNOGLOBULIN HEAVY CHAINS) make one immunoglobulin molecule. Ig Light Chains,Immunoglobulins, Light-Chain,Immunoglobulin Light Chain,Immunoglobulin Light-Chain,Light-Chain Immunoglobulins,Chains, Ig Light,Chains, Immunoglobulin Light,Immunoglobulins, Light Chain,Light Chain Immunoglobulins,Light Chain, Immunoglobulin,Light Chains, Ig,Light Chains, Immunoglobulin,Light-Chain, Immunoglobulin
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D011507 Proteinuria The presence of proteins in the urine, an indicator of KIDNEY DISEASES. Proteinurias
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G Paladini, and P G Sala, and P A Santini
Bence Jones proteins: malignant or benign?
March 1982, The New England journal of medicine,
G Paladini, and P G Sala, and P A Santini
[Transitory monoclonal gammopathy and Bence-Jones proteinuria in pneumonia].
September 1985, Presse medicale (Paris, France : 1983),
G Paladini, and P G Sala, and P A Santini
Feline lymphoplasmacytic stomatitis associated with monoclonal gammopathy and Bence-Jones proteinuria.
March 1994, Journal of veterinary dentistry,
G Paladini, and P G Sala, and P A Santini
[IgG (kappa) benign monoclonal gammopathy, IgG (kappa) multiple myeloma and Bence Jones (lambda) multiple myeloma in 3 brothers].
July 1987, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
G Paladini, and P G Sala, and P A Santini
[IgG-K benign monoclonal gammopathy, IgG-K multiple myeloma and Bence Jones-L multiple myeloma in three brothers].
February 1988, Rinsho byori. The Japanese journal of clinical pathology,
G Paladini, and P G Sala, and P A Santini
A case of feline IgA-monoclonal gammopathy associated with Bence Jones proteinuria.
June 1986, Nihon juigaku zasshi. The Japanese journal of veterinary science,
G Paladini, and P G Sala, and P A Santini
Multiple myeloma with serum IgG kappa and Bence Jones lambda biclonal gammopathy.
July 1987, Clinical chemistry,
G Paladini, and P G Sala, and P A Santini
Multiple myeloma with serum IgM kappa and Bence Jones lambda biclonal gammopathy.
December 1986, Clinical chemistry,
G Paladini, and P G Sala, and P A Santini
Long-term follow-up in "benign" Bence Jones proteinuria.
January 1985, Haematologica,
G Paladini, and P G Sala, and P A Santini
Bence Jones proteinuria in benign monoclonal gammapathies. Incidence and characteristics.
November 1968, Acta medica Scandinavica,
Copied contents to your clipboard!